Cost-effectiveness of simvastatin in the secondary prevention of coronary artery disease in Canada

 
Table 1: Average resource utilization values for 5 major cardiovascular events* associated with coronary artery disease (CAD) in Canada over a 3-month period
VariableMICABGPTCAStrokeTIA
No. of ambulance trips10010
Length of hospital stay, d893372
No. of physician consultations11156196
No. of visits by allied health
care workers
371691
No. of laboratory investigations
and procedures
1716999
No. of outpatient prescriptions1110277
Total51572114224
*MI = myocardial infarction, CABG = coronary artery bypass grafting, PTCA = percutaneous transluminal coronary angioplasty, TIA = transient ischemic attack

[Return to text]


| CMAJ April 1, 1997 (vol 156, no 7) / JAMC le 1er avril 1997 (vol 156, no 7) |
/ >